T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Bladder Carcinoma|Breast Cancer|Esophagus Carcinoma|Lung Cancer|Melanoma|Multiple Myeloma|Neuroblastoma|Ovarian Cancer|Synovial Sarcoma|Other Metastatic Solid Cancers
Interventions: DRUG: Cyclophosphamide|DRUG: Fludarabine|BIOLOGICAL: Anti-NY ESO-1 TCR-transduced T cells
Sponsor: Shenzhen Second People's Hospital
Collaborators: Shenzhen Institute for Innovation and Translational Medicine